A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease

More than 80 years after iron accumulation was initially described in the substantia nigra (SN) of Parkinson's disease (PD) patients, the mechanisms responsible for this phenomenon are still unknown. Similarly, how iron is delivered to its major recipients in the cell – mitochondria and the res...

Full description

Bibliographic Details
Main Authors: Pier Giorgio Mastroberardino, Eric K. Hoffman, Maxx P. Horowitz, Ranjita Betarbet, Georgia Taylor, Dongmei Cheng, Hye Mee Na, Claire-Anne Gutekunst, Marla Gearing, John Q. Trojanowski, Marjorie Anderson, Charleen T. Chu, Junmin Peng, J. Timothy Greenamyre
Format: Article
Language:English
Published: Elsevier 2009-06-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996109000357
id doaj-ae4df57a66d849599c7f41096719b598
record_format Article
spelling doaj-ae4df57a66d849599c7f41096719b5982021-03-20T04:57:15ZengElsevierNeurobiology of Disease1095-953X2009-06-01343417431A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's diseasePier Giorgio Mastroberardino0Eric K. Hoffman1Maxx P. Horowitz2Ranjita Betarbet3Georgia Taylor4Dongmei Cheng5Hye Mee Na6Claire-Anne Gutekunst7Marla Gearing8John Q. Trojanowski9Marjorie Anderson10Charleen T. Chu11Junmin Peng12J. Timothy Greenamyre13Department of Neurology, University of Pittsburgh, 3501 fifth avenue, Pittsburgh, PA 15260, USA; Pittsburgh Institute for Neurodegenerative Diseases, USA; Corresponding author. Department of Neurology, University of Pittsburgh, 3501 fifth avenue, Pittsburgh, PA 15260, USA Fax: +1 412 648 9766.Department of Neurology, University of Pittsburgh, 3501 fifth avenue, Pittsburgh, PA 15260, USA; Pittsburgh Institute for Neurodegenerative Diseases, USAMedical Scientist Training Program and Center for Neuroscience, University of Pittsburgh, USADepartment of Neurology, Center for Neurodegenerative Disease, Emory University, Atlanta, GA 30322, USADepartment of Neurology, Center for Neurodegenerative Disease, Emory University, Atlanta, GA 30322, USADepartment of Human Genetics, Center for Neurodegenerative Disease, Emory University, Atlanta, GA 30322, USADepartment of Neurology, University of Pittsburgh, 3501 fifth avenue, Pittsburgh, PA 15260, USA; Pittsburgh Institute for Neurodegenerative Diseases, USADepartment of Neurology, Center for Neurodegenerative Disease, Emory University, Atlanta, GA 30322, USADepartment of Pathology, Center for Neurodegenerative Disease, Emory University, Atlanta, GA 30322, USACenter for Neurodegenerative Disease Research, University of Pennsylvania, Philadelphia, PA 19104, USAUniversity of Washington, Department of Rehabilitation Medicine, Seattle, WA 98195, USAPittsburgh Institute for Neurodegenerative Diseases, USA; Department of Pathology, University of Pittsburgh, Pittsburgh, PA 15213, USADepartment of Human Genetics, Center for Neurodegenerative Disease, Emory University, Atlanta, GA 30322, USADepartment of Neurology, University of Pittsburgh, 3501 fifth avenue, Pittsburgh, PA 15260, USA; Pittsburgh Institute for Neurodegenerative Diseases, USAMore than 80 years after iron accumulation was initially described in the substantia nigra (SN) of Parkinson's disease (PD) patients, the mechanisms responsible for this phenomenon are still unknown. Similarly, how iron is delivered to its major recipients in the cell – mitochondria and the respiratory complexes – has yet to be elucidated. Here, we report a novel transferrin/transferrin receptor 2 (Tf/TfR2)-mediated iron transport pathway in mitochondria of SN dopamine neurons. We found that TfR2 has a previously uncharacterized mitochondrial targeting sequence that is sufficient to import the protein into these organelles. Importantly, the Tf/TfR2 pathway can deliver Tf bound iron to mitochondria and to the respiratory complex I as well. The pathway is redox-sensitive and oxidation of Tf thiols to disulfides induces release from Tf of highly reactive ferrous iron, which contributes to free radical production. In the rotenone model of PD, Tf accumulates in dopamine neurons, with much of it accumulating in the mitochondria. This is associated with iron deposition in SN, similar to what occurs in PD. In the human SN, TfR2 is also found in mitochondria of dopamine neurons, and in PD there is a dramatic increase of oxidized Tf in SN. Thus, we have discovered a novel mitochondrial iron transport system that goes awry in PD, and which may provide a new target for therapeutic intervention.http://www.sciencedirect.com/science/article/pii/S0969996109000357Parkinson's diseaseRotenoneOxidative stressMitochondriaIronTransferrin
collection DOAJ
language English
format Article
sources DOAJ
author Pier Giorgio Mastroberardino
Eric K. Hoffman
Maxx P. Horowitz
Ranjita Betarbet
Georgia Taylor
Dongmei Cheng
Hye Mee Na
Claire-Anne Gutekunst
Marla Gearing
John Q. Trojanowski
Marjorie Anderson
Charleen T. Chu
Junmin Peng
J. Timothy Greenamyre
spellingShingle Pier Giorgio Mastroberardino
Eric K. Hoffman
Maxx P. Horowitz
Ranjita Betarbet
Georgia Taylor
Dongmei Cheng
Hye Mee Na
Claire-Anne Gutekunst
Marla Gearing
John Q. Trojanowski
Marjorie Anderson
Charleen T. Chu
Junmin Peng
J. Timothy Greenamyre
A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease
Neurobiology of Disease
Parkinson's disease
Rotenone
Oxidative stress
Mitochondria
Iron
Transferrin
author_facet Pier Giorgio Mastroberardino
Eric K. Hoffman
Maxx P. Horowitz
Ranjita Betarbet
Georgia Taylor
Dongmei Cheng
Hye Mee Na
Claire-Anne Gutekunst
Marla Gearing
John Q. Trojanowski
Marjorie Anderson
Charleen T. Chu
Junmin Peng
J. Timothy Greenamyre
author_sort Pier Giorgio Mastroberardino
title A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease
title_short A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease
title_full A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease
title_fullStr A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease
title_full_unstemmed A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease
title_sort novel transferrin/tfr2-mediated mitochondrial iron transport system is disrupted in parkinson's disease
publisher Elsevier
series Neurobiology of Disease
issn 1095-953X
publishDate 2009-06-01
description More than 80 years after iron accumulation was initially described in the substantia nigra (SN) of Parkinson's disease (PD) patients, the mechanisms responsible for this phenomenon are still unknown. Similarly, how iron is delivered to its major recipients in the cell – mitochondria and the respiratory complexes – has yet to be elucidated. Here, we report a novel transferrin/transferrin receptor 2 (Tf/TfR2)-mediated iron transport pathway in mitochondria of SN dopamine neurons. We found that TfR2 has a previously uncharacterized mitochondrial targeting sequence that is sufficient to import the protein into these organelles. Importantly, the Tf/TfR2 pathway can deliver Tf bound iron to mitochondria and to the respiratory complex I as well. The pathway is redox-sensitive and oxidation of Tf thiols to disulfides induces release from Tf of highly reactive ferrous iron, which contributes to free radical production. In the rotenone model of PD, Tf accumulates in dopamine neurons, with much of it accumulating in the mitochondria. This is associated with iron deposition in SN, similar to what occurs in PD. In the human SN, TfR2 is also found in mitochondria of dopamine neurons, and in PD there is a dramatic increase of oxidized Tf in SN. Thus, we have discovered a novel mitochondrial iron transport system that goes awry in PD, and which may provide a new target for therapeutic intervention.
topic Parkinson's disease
Rotenone
Oxidative stress
Mitochondria
Iron
Transferrin
url http://www.sciencedirect.com/science/article/pii/S0969996109000357
work_keys_str_mv AT piergiorgiomastroberardino anoveltransferrintfr2mediatedmitochondrialirontransportsystemisdisruptedinparkinsonsdisease
AT erickhoffman anoveltransferrintfr2mediatedmitochondrialirontransportsystemisdisruptedinparkinsonsdisease
AT maxxphorowitz anoveltransferrintfr2mediatedmitochondrialirontransportsystemisdisruptedinparkinsonsdisease
AT ranjitabetarbet anoveltransferrintfr2mediatedmitochondrialirontransportsystemisdisruptedinparkinsonsdisease
AT georgiataylor anoveltransferrintfr2mediatedmitochondrialirontransportsystemisdisruptedinparkinsonsdisease
AT dongmeicheng anoveltransferrintfr2mediatedmitochondrialirontransportsystemisdisruptedinparkinsonsdisease
AT hyemeena anoveltransferrintfr2mediatedmitochondrialirontransportsystemisdisruptedinparkinsonsdisease
AT claireannegutekunst anoveltransferrintfr2mediatedmitochondrialirontransportsystemisdisruptedinparkinsonsdisease
AT marlagearing anoveltransferrintfr2mediatedmitochondrialirontransportsystemisdisruptedinparkinsonsdisease
AT johnqtrojanowski anoveltransferrintfr2mediatedmitochondrialirontransportsystemisdisruptedinparkinsonsdisease
AT marjorieanderson anoveltransferrintfr2mediatedmitochondrialirontransportsystemisdisruptedinparkinsonsdisease
AT charleentchu anoveltransferrintfr2mediatedmitochondrialirontransportsystemisdisruptedinparkinsonsdisease
AT junminpeng anoveltransferrintfr2mediatedmitochondrialirontransportsystemisdisruptedinparkinsonsdisease
AT jtimothygreenamyre anoveltransferrintfr2mediatedmitochondrialirontransportsystemisdisruptedinparkinsonsdisease
AT piergiorgiomastroberardino noveltransferrintfr2mediatedmitochondrialirontransportsystemisdisruptedinparkinsonsdisease
AT erickhoffman noveltransferrintfr2mediatedmitochondrialirontransportsystemisdisruptedinparkinsonsdisease
AT maxxphorowitz noveltransferrintfr2mediatedmitochondrialirontransportsystemisdisruptedinparkinsonsdisease
AT ranjitabetarbet noveltransferrintfr2mediatedmitochondrialirontransportsystemisdisruptedinparkinsonsdisease
AT georgiataylor noveltransferrintfr2mediatedmitochondrialirontransportsystemisdisruptedinparkinsonsdisease
AT dongmeicheng noveltransferrintfr2mediatedmitochondrialirontransportsystemisdisruptedinparkinsonsdisease
AT hyemeena noveltransferrintfr2mediatedmitochondrialirontransportsystemisdisruptedinparkinsonsdisease
AT claireannegutekunst noveltransferrintfr2mediatedmitochondrialirontransportsystemisdisruptedinparkinsonsdisease
AT marlagearing noveltransferrintfr2mediatedmitochondrialirontransportsystemisdisruptedinparkinsonsdisease
AT johnqtrojanowski noveltransferrintfr2mediatedmitochondrialirontransportsystemisdisruptedinparkinsonsdisease
AT marjorieanderson noveltransferrintfr2mediatedmitochondrialirontransportsystemisdisruptedinparkinsonsdisease
AT charleentchu noveltransferrintfr2mediatedmitochondrialirontransportsystemisdisruptedinparkinsonsdisease
AT junminpeng noveltransferrintfr2mediatedmitochondrialirontransportsystemisdisruptedinparkinsonsdisease
AT jtimothygreenamyre noveltransferrintfr2mediatedmitochondrialirontransportsystemisdisruptedinparkinsonsdisease
_version_ 1724211670907092992